Admedus Immunotherapies

Learn More Global Healthcare Company


Admedus Tissue Engineering

Learn More Healthcare Innovations - Baby Tissue Engineering


Admedus Medical Products

Learn More Hospital Equipment Australia

Welcome to Admedus

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.

Learn More

CardioCel regenerative tissue scaffold

CardioCel® is a superior cardiovascular bioscaffold used to repair and reconstruct heart defects.

Read More

Our range of medical products and devices combine quality and value with the very latest technology

View our full range of products

News & Media

< >

Admedus a major distributor of leading infusion solutions

Many people would have heard about the great work Admedus is doing in the field of tissue engineering and immunotherapies, but fewer people would know that Admedus is also a major distributor of infusion solutions (intravenous products and infusion pumps) to hospitals in Australia and New Zealand. The highly successful infusion portfolio has been part […]

June 10th 2016

Find out more
mass device logo

Admedus shares rise on hospital infusion pump supply deal with Arcomed

Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.

May 25th 2016

Find out more

Admedus Wins 2016 Australian Manufacturer of the Year Award

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

May 14th 2016

Find out more

A day with Europe’s leading cardiovascular surgeons

In April, I had the privilege of spending the day with over forty of Europe’s leading cardiovascular surgeons. The purpose – an Admedus workshop to discuss the use of CardioCel to reconstruct heart valves and its potential in the future treatment of heart valve disease. Held in Amsterdam, the experts meeting shed light on the critical issues and […]

May 5th 2016

Find out more
The Australian Logo

Admedus HSV-2 clinical results encouraging – Morgans

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

March 7th 2016

Find out more

Upcoming Events

Aortic Valve Repair Summit

July 1st 2016 See event details
4th Singapore Valve 2016

July 14th 2016 See event details
30th EACTS Annual Meeting

October 1st 2016 See event details
Australian & New Zealand Society of Cardiac & Thoracic Surgeons

November 6th 2016 See event details